ArticleCureus2026
Thyroid Status and Sperm Abnormality Phenotypes Among Infertile Males Attending a Tertiary Referral Center in Bangladesh: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Thyroid hormones triiodothyronine (T3) and thyroxine (T4) are recognized modulators of male reproductive physiology, acting on Sertoli cells, Leydig cells, and germ cells to regulate spermatogenesis. Despite growing evidence linking thyroid dysfunction to altered semen quality, the association between thyroid status and specific sperm abnormality phenotypes remains insufficiently characterized, with no prior data available from Bangladesh. This study aimed to evaluate thyroid status and its association with sperm abnormality phenotypes among infertile males attending a tertiary referral center in Bangladesh. Methods A hospital-based cross-sectional observational study was conducted at the Reproductive Endocrinology and Infertility outpatient department and In Vitro Fertilization (IVF) Center, Dhaka Medical College Hospital, Bangladesh, from January 2025 to June 2025. Ninety infertile males aged 21-50 years with confirmed abnormal semen parameters were enrolled using purposive sampling. Participants were classified into four phenotypic groups per WHO 2021 sixth edition criteria: oligospermia, isolated asthenozoospermia, oligo-asthenozoospermia, and astheno-teratozoospermia. Individuals with chronic systemic diseases independently associated with altered thyroid or reproductive function were excluded. Serum T3, T4, TSH, and follicle-stimulating hormone (FSH) were measured by chemiluminescence immunoassay (CLIA). Statistical analysis included the Kruskal-Wallis test, Mann-Whitney U test, chi-squared test, and Spearman rank correlation, using SPSS version 26 (IBM Inc., Armonk, New York). Results The median age was 35.0 years (IQR: 30.0-38.5). Oligospermia was the most prevalent phenotype (62.2%), followed by oligo-asthenozoospermia (22.2%) and isolated asthenozoospermia (12.2%). Hypothyroidism was disproportionately prevalent among men with oligo-asthenozoospermia (70.0%), while hyperthyroidism was more frequent among asthenozoospermic men (27.3%). Statistically significant differences in serum T3 (p=0.017), T4 (p=0.041), and TSH (p=0.003) were observed across phenotypic groups. Thyroid status was significantly associated with semen abnormality type (p<0.001). Serum T3 and T4 correlated positively with total sperm count (rs=0.427 and 0.422, respectively) and sperm morphology (rs=0.532 and 0.370), while TSH showed significant inverse correlations with both parameters. No significant correlation was observed with sperm motility. Conclusions Thyroid dysfunction, particularly hypothyroidism, was significantly associated with specific sperm abnormality phenotypes among infertile males in Bangladesh. Thyroid hormone levels correlated meaningfully with sperm count and morphology, suggesting that thyroid evaluation may be considered as part of the male infertility workup. Larger, multicenter, longitudinal studies are needed to confirm these associations and guide clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.